How has dialysis impacted your mental health? A realist evaluation: Why, for whom, in what circumstances does CBT work for people with depressive symptoms receiving dialysis?

Study Lead

Dr. Kara Schick-Makaroff

University of Alberta

Overview

Although common amongst dialysis patients, depression is rarely treated. We know Cognitive Behavioural Therapy (CBT) is helpful form of therapy, but how does it work in dialysis care? Why does it help some, but not all? Who benefits the most? This study will answer these questions to help dialysis programs move towards making a solution available to patients.

Participant Commitment

Participants will be asked to fill out online surveys regularly over 6 months. The surveys will ask about their quality of life, mental health, and health care. The first survey takes approximately 30 – 60 minutes to complete. The following surveys may take 5 – 15 minutes to complete.

Participants who complete the surveys will receive gift cards as a thank-you for their time and effort.

Eligibility

  • On dialysis for at least 1 year
  • Adults (at least 18 or 19 years and older)
  • Able to fill out online surveys on your own
  • Able to read and speak English

Type of Participation

Survey

Treatment

Hemodialysis, Peritoneal Dialysis

Topic

Peer Support, Quality of Life, Self-Management, Symptoms

Location

All provinces and territories

Related studies

  • Promoting shared decision making for people with advanced chronic kidney disease

    Overview:

    Study type: Focus Group

    August 8, 2024

  • Improving the Care and Experiences of Living Kidney Donors

    Overview: Seeking family physicians and transplant healthcare professionals for an online interview that will help develop tools to improve the experiences, care, and outcomes of living kidney donors.

    Study type: Interview

    July 25, 2024

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024